NorthSea Therapeutics lands Series B
Dutch biotech firm NorthSea Therapeutics has secured $40 million in Series B funding.
Dutch biotech firm NorthSea Therapeutics has secured $40 million in Series B funding.
Copyright PEI Media
Not for publication, email or dissemination